NZ526906A - Novel receptors for Helicobacter pylori and use thereof - Google Patents

Novel receptors for Helicobacter pylori and use thereof

Info

Publication number
NZ526906A
NZ526906A NZ526906A NZ52690602A NZ526906A NZ 526906 A NZ526906 A NZ 526906A NZ 526906 A NZ526906 A NZ 526906A NZ 52690602 A NZ52690602 A NZ 52690602A NZ 526906 A NZ526906 A NZ 526906A
Authority
NZ
New Zealand
Prior art keywords
helicobacter pylori
binding
substance
oligosaccharide
nac
Prior art date
Application number
NZ526906A
Other languages
English (en)
Inventor
Halina Miller-Podraza
Susann Teneberg
Jonas Angstrom
Karl-Anders Karlsson
Jari Natunen
Original Assignee
Biotie Therapies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Corp filed Critical Biotie Therapies Corp
Publication of NZ526906A publication Critical patent/NZ526906A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NZ526906A 2001-01-19 2002-01-18 Novel receptors for Helicobacter pylori and use thereof NZ526906A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010118A FI20010118L (fi) 2001-01-19 2001-01-19 Uudet helicobacter pylori reseptorit ja niiden käyttö
PCT/FI2002/000043 WO2002056893A1 (en) 2001-01-19 2002-01-18 Novel receptors for $i(helicobacter pylori) and use thereof

Publications (1)

Publication Number Publication Date
NZ526906A true NZ526906A (en) 2005-03-24

Family

ID=8560066

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ526906A NZ526906A (en) 2001-01-19 2002-01-18 Novel receptors for Helicobacter pylori and use thereof

Country Status (19)

Country Link
US (1) US20040096465A1 (enExample)
EP (1) EP1359922A1 (enExample)
JP (1) JP2004519459A (enExample)
KR (1) KR100886777B1 (enExample)
CN (1) CN100455290C (enExample)
AU (1) AU2002229792B2 (enExample)
CA (1) CA2434350A1 (enExample)
CZ (1) CZ20031914A3 (enExample)
EE (1) EE200300339A (enExample)
FI (1) FI20010118L (enExample)
HU (1) HUP0302790A3 (enExample)
IL (1) IL156992A0 (enExample)
NO (1) NO20033270L (enExample)
NZ (1) NZ526906A (enExample)
PL (1) PL363617A1 (enExample)
RU (1) RU2306140C2 (enExample)
SK (1) SK10042003A3 (enExample)
WO (1) WO2002056893A1 (enExample)
ZA (1) ZA200305155B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20011671A7 (fi) 2001-08-20 2003-02-21 Carbion Oy Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
US20050220819A1 (en) * 2002-01-18 2005-10-06 Biotie Therapies Oyj Novel binding epitopes for helicobacter pylori and use thereof
EP1531832B1 (en) * 2002-06-28 2009-04-15 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
WO2004065400A1 (en) * 2003-01-20 2004-08-05 Glykos Finland Oy Novel binding epitopes for helicobacter pylori and use thereof
JP5035787B2 (ja) * 2005-10-04 2012-09-26 焼津水産化学工業株式会社 α−１、４結合型Ｎ−アセチルグルコサミン含有Ｏ−グリカン型糖鎖の分泌促進剤並びにこれを含有するヘリコバクターピロリ菌を原因とする病態の治療予防剤
JP5140246B2 (ja) * 2006-03-15 2013-02-06 公益財団法人野口研究所 Ｎ−アセチルグルコサミンの誘導体を含有するピロリ菌増殖抑制剤
JP5014018B2 (ja) * 2006-10-18 2012-08-29 旭化成ケミカルズ株式会社 ピロリ菌の抑制剤または静菌剤
US8075674B2 (en) 2006-11-30 2011-12-13 Donaldson Company, Inc. Filter apparatus with pulse cleaning and methods for pulse cleaning filters
US20100233198A1 (en) * 2007-11-08 2010-09-16 Nestec S.A. Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
AU2013237497B2 (en) * 2012-03-19 2016-05-12 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Carbohydrate-glycolipid conjugate vaccines
AU2013338153B2 (en) * 2012-10-29 2018-06-21 The Board Of Trustees Of The University Of Arkansas Novel mucosal adjuvants and delivery systems
CN112023037A (zh) * 2020-09-09 2020-12-04 四川大学 一种聚糖在制备对Hp感染的预防和治疗产品中的应用、产品及制备方法
CN112285338B (zh) * 2020-10-20 2023-04-28 四川大学华西医院 一种copd诊断试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8203925D0 (sv) * 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
KR960022566A (ko) * 1994-12-30 1996-07-18 김충환 신규한 아미노올리고당 유도체 및 그의 제조방법
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
JPH1045602A (ja) * 1996-07-31 1998-02-17 Motoyasu Murakami ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof

Also Published As

Publication number Publication date
KR20040018329A (ko) 2004-03-03
FI20010118A7 (fi) 2002-07-20
ZA200305155B (en) 2004-07-19
US20040096465A1 (en) 2004-05-20
AU2002229792B2 (en) 2007-08-16
CA2434350A1 (en) 2002-07-25
HUP0302790A2 (hu) 2003-11-28
CZ20031914A3 (cs) 2004-04-14
FI20010118L (fi) 2002-07-20
CN1525862A (zh) 2004-09-01
PL363617A1 (pl) 2004-11-29
JP2004519459A (ja) 2004-07-02
HUP0302790A3 (en) 2010-01-28
RU2306140C2 (ru) 2007-09-20
FI20010118A0 (fi) 2001-01-19
EP1359922A1 (en) 2003-11-12
CN100455290C (zh) 2009-01-28
SK10042003A3 (sk) 2003-11-04
NO20033270D0 (no) 2003-07-18
IL156992A0 (en) 2004-02-08
KR100886777B1 (ko) 2009-03-04
RU2003125370A (ru) 2005-02-10
WO2002056893A1 (en) 2002-07-25
WO2002056893A8 (en) 2003-11-13
EE200300339A (et) 2003-10-15
NO20033270L (no) 2003-09-19

Similar Documents

Publication Publication Date Title
EP2272522B1 (en) Therapeutic compositions for use in prophylaxis or treatment of diarrheas
EP1411952B1 (en) Use of at least one glycoinhibitor substance against infectious diseases
AU2002229792B2 (en) Novel receptors for Helicobacter pylori and use thereof
US20040180850A1 (en) Methods and compositions for treatment of gastric diseases
AU2002229792A1 (en) Novel receptors for Helicobacter pylori and use thereof
US20060122148A1 (en) High affinity receptors for helicobacter pylori and use thereof
AU783876B2 (en) Novel helicobacter pylori-binding substances and use thereof
US20050220819A1 (en) Novel binding epitopes for helicobacter pylori and use thereof
WO2004065400A1 (en) Novel binding epitopes for helicobacter pylori and use thereof
Natunen Use of at least one glycoinhibitor substance

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)